Changes in sleep and wakefulness following 5-HT1A ligands given systemically and locally in different brain regions. (Q48307727)

10 February 2018

review article

1 reference

title

Changes in sleep and wakefulness following 5-HT1A ligands given systemically and locally in different brain regions. (English)

1 reference

10 February 2018

1

Bjorvatn B

1 reference

10 February 2018

Reidun Ursin

series ordinal

2

object named as

Ursin R

1 reference

10 February 2018

publication date

1 January 1998

1 reference

10 February 2018

Reviews in the Neurosciences

published in

1 reference

10 February 2018

volume

9

1 reference

10 February 2018

issue

4

1 reference

10 February 2018

page(s)

265-273

1 reference

10 February 2018

The 5-HT1A receptor antagonist p-MPPI blocks responses mediated by postsynaptic and presynaptic 5-HT1A receptors.

cites work

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Low brain uptake of L-[11C]5-hydroxytryptophan in major depression: a positron emission tomography study on patients and healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Sleep/waking effects of a selective 5-HT1A receptor agonist given systemically as well as perfused in the dorsal raphe nucleus in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

The 5-HT1A antagonist (-)-alprenolol fails to modify sleep or zimeldine-induced sleep-waking effects in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Effects of zimeldine, a selective 5-HT reuptake inhibitor, combined with ritanserin, a selective 5-HT2 antagonist, on waking and sleep stages in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Effects of the selective 5-HT1B agonist, CGS 12066B, on sleep/waking stages and EEG power spectrum in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Current advances and trends in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

The influence of ipsapirone, a 5-HT1A agonist, on sleep patterns of healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Functional activity of 5-HT2 receptors in the modulation of the sleep/wakefulness states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

5-HT1-like receptor agonists enhance wakefulness

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Effect of antipsychotic drugs on the firing of dorsal raphe cells. I. Role of adrenergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Fluoxetine decreases brain temperature and REM sleep in Syrian hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Ipsapirone, a 5-HT1A agonist, suppresses REM sleep equally in unmedicated depressed patients and normal controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Serotonergic synaptic input to cholinergic neurons in the rat mesopontine tegmentum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

5-HT receptor classification and nomenclature: towards a harmonization with the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Biogenic amines and the states of sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Pharmacological and immunohistochemical evidence for serotonergic modulation of cholinergic nucleus basalis neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Cholinergic nucleus basalis neurons display the capacity for rhythmic bursting activity mediated by low-threshold calcium spikes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Effects of the selective 5-hydroxytryptamine uptake inhibitors paroxetine and zimeldine on EEG sleep and waking stages in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

The effect of para-chlorophenylalanine on the sleep of cats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Serotonergic and cholinergic inhibition of mesopontine cholinergic neurons controlling REM sleep: an in vitro electrophysiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

5-HT1 receptors and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Serotonin hyperpolarizes cholinergic low-threshold burst neurons in the rat laterodorsal tegmental nucleus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Dorsal raphe neurons: depression of firing during sleep in cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Dose-dependent effects of the 5-HT1A receptor agonist 8-OH-DPAT on sleep and wakefulness in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Stereoselective antagonism by the pindolol enantiomers of 8-OH-DPAT-induced changes of sleep and wakefulness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Depletion of brain serotonin by 5,7-DHT: effects on the 8-OH-DPAT-induced changes of sleep and waking in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Sleep and EEG power spectrum effects of the 5-HT1A antagonist NAN-190 alone and in combination with citalopram.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Unit activity of rat basal forebrain neurons: relationship to cortical activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Diurnal differences in L-tryptophan sleep and temperature effects in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Short-term effects of fluoxetine and trifluoromethylphenylpiperazine on electroencephalographic sleep in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

The effects of selective activation of the 5-HT3 receptor with m-chlorophenylbiguanide on sleep and wakefulness in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

On-line detection of extracellular levels of serotonin in dorsal raphe nucleus and frontal cortex over the sleep/wake cycle in the freely moving rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

5-HT antagonists suppress sleep and delay its restoration after 5-HTP in p-chlorophenylalanine-pretreated cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Central administration of two 5-HT receptor agonists: effect on REM sleep initiation and PGO waves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Human sleep EEG following the 5-HT1A antagonist pindolol: possible disinhibition of raphe neuron activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Behavioral, sleep-waking and EEG power spectral effects following the two specific 5-HT uptake inhibitors zimeldine and alaproclate in cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

l-Tryptophan: Effects on daytime sleep latency and the waking EEG

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Effects of ipsapirone, a 5-HT1A agonist, on sleep/wakefulness cycles: probable post-synaptic action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

The effect of 3-h and 6-h sleep deprivation on sleep and EEG spectra of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Suppressant effects of selective 5-HT2 antagonists on rapid eye movement sleep in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Raphe unit activity in freely moving cats: Correlation with level of behavioral arousal

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Differential effect of para-chlorophenylalanine on the two slow wave sleep stages in the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

The effects of 5-hydroxytryptophan andl-tryptophan on wakefulness and sleep patterns in the cat

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Increased waking as well as increased synchronization following administration of selective 5-HT uptake inhibitors to rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

Increased sleep following intracerebroventricular injection of the delta sleep-inducing peptide in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1998.9.4.265

10.1515/REVNEURO.1998.9.4.265

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

9886141

1 reference

10 February 2018